HLB Life Science Co., Ltd. (067630.KQ)

HLB Life Science Co., Ltd. (067630.KQ) — VMCI valuation read

067630.KQ screens at VMCI 26/100, a 24-point gap below the Utilities sector median (50). For a mid-cap HLB Life Science Co., Ltd. share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

067630.KQ has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 067630.KQ trades at 26.0x earnings, 44% above the Utilities median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Utilities group. Quality: ROIC of 16.0% sits 6.0pp above the Utilities median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 0.1x leaves covenant headroom, which sets the rate-cycle exposure for HLB Life Science Co., Ltd..

067630.KQ held flat 0.0% over the trailing 7 days, with a -7.8% read on a 30-day basis.